Skip to content

Intramedullary Fixation of Humerus Fractures

A Study Evaluating the Quantum - Composite Nailing System for Intramedullary Fixation of Humerus Fractures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01017289
Enrollment
20
Registered
2009-11-20
Start date
2009-12-31
Completion date
2011-12-31
Last updated
2009-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Humeral Fractures, Pathological Fractures

Brief summary

The purpose of the study is to evaluate the safety and efficacy of the composite Nail - the Quantum interlocking intramedullary nailing system in the reduction of humeral fractures.

Detailed description

The study will include 20 patients who have an acute mid shaft diaphyseal humeral fracture due to injury. The patients will undergo lateral and AP X- ray evaluation of the fracture. Following General anesthesia, closed reduction of the fracture will be performed. It will be followed by nail insertion, percutaneously, according to standard surgical techniques, with the help of the insertion handle. Following insertion the nail will be locked both distally and proximally using interlocking screws. The nail and screws insertion will be monitored by fluoroscopy. Patients will remain under follow up for 6 months following the procedure. In the follow up sessions the fracture will be evaluated by fluoroscopy or X-ray for correct bone alignment, callus formation, and fracture union.

Interventions

DEVICEQuantum

Treatment of humerus fracture (according to the mentioned indications) with the Quantum Intramedullary Nailing System.

Sponsors

N.M.B. Medical Applications Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Above 18 years old. * Mid shaft diaphyseal fracture * Acute fracture

Exclusion criteria

* Patients with metabolic or hormonal diseases that could affect bone healing such as diabetes. * Ongoing infection in fracture site.

Design outcomes

Primary

MeasureTime frame
Bone union and callus formationup to 6 months
Bone alignmentup to 6 months
Nail and screws resistance over timeup to 6 months

Countries

Israel

Contacts

Primary ContactMichael Bernstein, Orthopedic
+972 50 544 0966

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026